ATE214942T1 - Fibrinogen-bildungsprotein - Google Patents

Fibrinogen-bildungsprotein

Info

Publication number
ATE214942T1
ATE214942T1 AT93921159T AT93921159T ATE214942T1 AT E214942 T1 ATE214942 T1 AT E214942T1 AT 93921159 T AT93921159 T AT 93921159T AT 93921159 T AT93921159 T AT 93921159T AT E214942 T1 ATE214942 T1 AT E214942T1
Authority
AT
Austria
Prior art keywords
formation protein
protein
fragment
fibrinogen formation
fibrinogen
Prior art date
Application number
AT93921159T
Other languages
English (en)
Inventor
Maria K Boden
Jan-Ingmar Flock
Original Assignee
Alfa Laval Agri Internat Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9202720A external-priority patent/SE9202720D0/xx
Priority claimed from SE9302955A external-priority patent/SE9302955D0/xx
Application filed by Alfa Laval Agri Internat Ab filed Critical Alfa Laval Agri Internat Ab
Application granted granted Critical
Publication of ATE214942T1 publication Critical patent/ATE214942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93921159T 1992-09-21 1993-09-20 Fibrinogen-bildungsprotein ATE214942T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9202720A SE9202720D0 (sv) 1992-09-21 1992-09-21 Fibrinogen binding protein
SE9302955A SE9302955D0 (sv) 1993-09-13 1993-09-13 A fibrinogen binding protein
PCT/SE1993/000759 WO1994006830A1 (en) 1992-09-21 1993-09-20 Fibrinogen binding protein

Publications (1)

Publication Number Publication Date
ATE214942T1 true ATE214942T1 (de) 2002-04-15

Family

ID=26661530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921159T ATE214942T1 (de) 1992-09-21 1993-09-20 Fibrinogen-bildungsprotein

Country Status (7)

Country Link
US (1) US6299879B1 (de)
EP (1) EP0621875B1 (de)
AT (1) ATE214942T1 (de)
AU (1) AU4837193A (de)
CA (1) CA2124210A1 (de)
DE (1) DE69331758T2 (de)
WO (1) WO1994006830A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648240A (en) * 1994-05-24 1997-07-15 Texas A&M University MHC II analog from Staphylococcus aureus
CA2192175A1 (en) * 1994-06-07 1995-12-21 Ambrose Cheung Surface protein of staphylococcus aureus
SE9402490D0 (sv) * 1994-07-15 1994-07-15 Jan Ingmar Flock Vitronection binding protein
US6013482A (en) 1996-10-15 2000-01-11 Smithkline Beecham Plc Cell surface protein compounds
US5858709A (en) * 1996-10-15 1999-01-12 Smithkline Beecham P.L.C. Fibronectin binding protein B compounds
JPH11514870A (ja) * 1995-10-16 1999-12-21 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 新規な唾液結合タンパク質
GB9521146D0 (en) * 1995-10-16 1995-12-20 Smithkline Beecham Plc Novel compounds
WO1997014801A1 (en) * 1995-10-16 1997-04-24 Smithkline Beecham Plc Novel cell surface protein compounds
SE9602496D0 (sv) * 1996-06-20 1996-06-20 Bengt Guss Method and means for producing a fibrinogen binding protein and its use in biotechnology
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
US6107071A (en) * 1996-09-24 2000-08-22 Smithkline Beecham Corporation Histidinol dehydrogenase
CA2310217A1 (en) * 1997-11-26 1999-06-03 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US20030105020A1 (en) * 2001-11-16 2003-06-05 Jan-Ingmar Flock Use of a composition
WO2003041726A1 (en) * 2001-11-16 2003-05-22 Biostapro Ab Use of an extracellular adherence protein for the manufacture of an anti-inflammatory drug
US20070053925A1 (en) * 2003-04-16 2007-03-08 Eric Brown Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation
DE602004031836D1 (de) 2003-07-08 2011-04-28 Umc Utrecht Holding Bv Therapeutische verwendung von lpi, einem inhibitor des lectinwegs in staphylokokken bei entzündungskrankheiten
EP2503008B1 (de) 2007-04-19 2015-04-01 Molecular Detection Inc. Verfahren, Zusammensetzungen und Kits zur Erkennung und Analyse von Antibiotika-resistenten Bakterien
WO2009029831A1 (en) * 2007-08-31 2009-03-05 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
KR101773368B1 (ko) 2009-04-03 2017-08-31 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
CN103037885B (zh) 2010-07-02 2015-08-26 芝加哥大学 与蛋白A(SpA)变体相关的组合物和方法
CN101987866B (zh) * 2010-10-25 2013-01-23 中国人民解放军军事医学科学院基础医学研究所 金黄色葡萄球菌Efb蛋白C端抗原表位及其制备方法和用途
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CA2937054C (en) * 2014-01-24 2023-02-14 William R. Church Antibody specific to staphylococcus aureus, therapeutic method and detection method using same
US11345744B2 (en) 2019-05-07 2022-05-31 William R Church Antibody specific to Staphylococcus aureus, therapeutic method and detection method using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189015A (en) 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
SE454403B (sv) * 1984-05-30 1988-05-02 Alfa Laval Agri Int Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel

Also Published As

Publication number Publication date
DE69331758D1 (de) 2002-05-02
EP0621875B1 (de) 2002-03-27
AU4837193A (en) 1994-04-12
EP0621875A1 (de) 1994-11-02
WO1994006830A1 (en) 1994-03-31
US6299879B1 (en) 2001-10-09
DE69331758T2 (de) 2002-11-14
CA2124210A1 (en) 1994-03-31

Similar Documents

Publication Publication Date Title
ATE214942T1 (de) Fibrinogen-bildungsprotein
DK0654078T3 (da) Thrombinblodfraktion til anvendelse i en medicinsk procedure
DE69124371D1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
NO901399D0 (no) Aminosyrederivater.
DK1175909T3 (da) Terapeutiske sammensætninger af antistoffer og antisense-nukleinsyrer mod Serrate
NO903832L (no) Aminosyrederivater.
NO901033L (no) Aminosyrederivater.
AP9200410A0 (en) Retroviral protease inhibitors.
ATE165976T1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
ATE304371T1 (de) Verwendung von staphylococcus enterotoxin homologe für krebs-therapie
DK162421C (da) Hundeparvovirus-vaccine, fremgangsmaade til fremstilling heraf og virusstamme til brug i vaccinen
DK0495918T3 (da) Aminosyre-beta-lyaseenzyminhibitorer som deodoranter
EA199800717A1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
NO884434D0 (no) Aminosyrederivater.
NO901533D0 (no) Aminosyrederivater.
DK675389A (da) Terapeutiske praeparater til forebyggelse af fibrinaflejringer
ES2092067T3 (es) Procedimiento de purificacion de una proteina altamente glicosilada.
DE3875859D1 (de) Zubereitungen zur verbesserung der adcc-therapien.
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE69433745D1 (de) Modifizierte, verkürzte regulatoren des komplementsystems
NO901519L (no) Aminosyrederivater.
FR2646607B1 (fr) Anticorps monoclonaux anti-b2 microglobuline
ES504996A0 (es) Un procedimiento para aislar un polipeptido purificado

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties